Multicomponent Synthesis of the SARS-CoV-2 Main Protease Inhibitor Nirmatrelvir

[Image: see text] In the wake of the Covid-19 pandemic, it has become clear that global access to efficacious antiviral drugs will be critical to combat future outbreaks of SARS-CoV-2 or related viruses. The orally available SARS-CoV-2 main protease inhibitor nirmatrelvir has proven an effective tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Preschel, H. Daniel, Otte, Ruben T., Zhuo, Ying, Ruscoe, Rebecca E., Burke, Ashleigh J., Kellerhals, Rachel, Horst, Brendan, Hennig, Sven, Janssen, Elwin, Green, Anthony P., Turner, Nicholas J., Ruijter, Eelco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476182/
https://www.ncbi.nlm.nih.gov/pubmed/37607396
http://dx.doi.org/10.1021/acs.joc.3c01274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476182/
https://www.ncbi.nlm.nih.gov/pubmed/37607396
http://dx.doi.org/10.1021/acs.joc.3c01274

Ejemplares similares